Uricosuric Agents
- Name
- Uricosuric Agents
- Accession Number
- DBCAT001241
- Description
Gout suppressants that act directly on the renal tubule to increase the excretion of uric acid, thus reducing its concentrations in plasma.
- Drugs
Drug Drug Description Allopurinol A xanthine oxidase inhibitor used to reduce urinary and serum uric acid concentrations in patients with gout, recurrent calcium oxalate calculi, and various malignancies. Azapropazone Not Available Benzbromarone A uricosuric agent which is taken daily for the prevention of gout flares. Benziodarone Benziodarone is a uricostatic and a uricosuric agent which is sold also under the name Amplivex-Labaz. It is used in the treatment of gout . It was withdrawn from France... Dotinurad Dotinurad is under investigation in clinical trial NCT03372200 (Febuxostat-controlled, Double-blind, Comparative Study of FYU-981 in Hyperuricemia With or Without Gout). Lesinurad A uric acid 1 transporter inhibitor typically used in combination with a xanthine oxidase inhibitor to treat hyperuricemia associated with gout in patients with inadequate control of uric acid levels with xanthine oxidase inhibitor monotherapy. Probenecid A medication used to treat gouty arthritis, tophaceous gout, and hyperuricemia. Sulfinpyrazone A platelet inhibitory and uricosuric agent used to inhibit thrombotic and embolic processes and to manage the chronic phases of gout . Tienilic acid For the treatment of hypertension. Traxanox Traxanox is a small molecule drug. Traxanox has a monoisotopic molecular weight of 299.02 Da. Zoxazolamine Not Annotated - Drugs & Drug Targets